These results may argue that there is a degradation inhibitory role for ERdj3 in the AAT trafficking pathway that is beneficial for the normal variant and similarly results in ZAAT polymer formation in AATD. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.